Hims & Hers Health, Inc.SEC Filings
|
|
All SEC filings by Hims & Hers Health, Inc. (HIMS) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 10, 2026 | |
| 10-Q | Quarterly report | View Diff | May 11, 2026 | |
| ARS | Annual report to shareholders | Apr 28, 2026 | ||
| 10-K | Annual report | View Diff | Feb 23, 2026 | |
| 10-Q | Quarterly report | View Diff | Nov 3, 2025 | |
| 10-Q | Quarterly report | View Diff | Aug 4, 2025 | |
| 10-Q | Quarterly report | View Diff | May 5, 2025 | |
| ARS | Annual report to shareholders | Apr 25, 2025 | ||
| 10-K | Annual report | View Diff | Feb 24, 2025 | |
| 10-Q | Quarterly report | View Diff | Nov 4, 2024 |
Events
| 8-K | Hims Hers Health, Inc. Reports Second Quarter 2026 Financial Results | Aug 10, 2026 | ||
| 8-K | Current report | Jul 17, 2026 | ||
| 8-K | Current report | Jul 1, 2026 | ||
| 8-K | Current report | Jun 15, 2026 | ||
| 8-K | Current report | Jun 2, 2026 | ||
| 8-K | Entry Into a Material Definitive Agreement | May 21, 2026 | ||
| 8-K | Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering To | May 19, 2026 | ||
| 8-K | Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results | May 11, 2026 | ||
| 8-K | Hims & Hers Announces Strategic Shift for Us Weight Loss Business | Mar 11, 2026 | ||
| 8-K | Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Feb 23, 2026 |
Registrations and Prospectuses
| S-8 | Registration of securities for employees | Feb 24, 2026 | ||
| S-8 | Registration of securities for employees | Feb 24, 2025 | ||
| 424B7 | Prospectus with selling stockholder info | Sep 9, 2024 | ||
| S-3ASR | Automatic shelf registration | Sep 9, 2024 | ||
| S-8 | Registration of securities for employees | Feb 26, 2024 | ||
| S-8 | Registration of securities for employees | Feb 28, 2023 | ||
| S-8 | Registration of securities for employees | Mar 9, 2022 | ||
| 424B3 | Prospectus supplement | Feb 10, 2022 | ||
| POS AM | Prospectus update (post-effective amendment) | Feb 4, 2022 | ||
| 424B3 | Prospectus supplement | Jan 20, 2022 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Apr 28, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 28, 2026 | |
| DEFA14A | Additional proxy soliciting materials | Apr 25, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 25, 2025 | |
| DEF 14A | Definitive proxy | View Diff | Apr 26, 2024 | |
| DEF 14A | Definitive proxy | View Diff | Apr 28, 2023 | |
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2022 | |
| DEF 14A | Definitive proxy | May 17, 2021 |
Other
| UPLOAD | Letter from SEC | Apr 17, 2025 | ||
| CORRESP | Correspondence with SEC | Apr 14, 2025 | ||
| UPLOAD | Letter from SEC | Oct 14, 2022 | ||
| CORRESP | Correspondence with SEC | Oct 11, 2022 | ||
| UPLOAD | Letter from SEC | Sep 27, 2022 | ||
| EFFECT | Notice of effectiveness | Feb 8, 2022 | ||
| EFFECT | Notice of effectiveness | Jun 4, 2021 | ||
| EFFECT | Notice of effectiveness | Mar 24, 2021 | ||
| EFFECT | Notice of effectiveness | Feb 12, 2021 | ||
| CORRESP | Correspondence with SEC | Feb 11, 2021 |
Ownership
| 4 | Boughton Soleil | Sep 3, 2026 | ||
| 144 | Notice of proposed sale of securities | Sep 2, 2026 | ||
| SC 13D/A | Dudum Andrew Updates Stake in Hims & Hers Health, Inc. | Aug 31, 2026 | ||
| 4 | Dudum Andrew | Aug 27, 2026 | ||
| 4 | Autor Deborah M. | Aug 20, 2026 | ||
| 4 | Okupe Oluyemi | Aug 20, 2026 | ||
| 4 | Boughton Soleil | Aug 20, 2026 | ||
| 144 | Notice of proposed sale of securities | Aug 19, 2026 | ||
| 4 | Boughton Soleil | Aug 18, 2026 | ||
| 4 | Schultz Kare | Aug 18, 2026 |